CRISP3 and ovarian cancer: In addition, the dopamine receptor D5 gene (DRD5) was described to be involved in tumor growth inhibition via autophagic cell death [15], NCOR2 was described to be associated with drug resistance in breast cancers [16] and CRISP3 was associated with prostate [17] and ovarian cancers [18].